635 results on '"Hayman, James A."'
Search Results
152. Concurrent whole brain radiotherapy and bortezomib for brain metastasis
153. Expectations About the Effectiveness of Radiation Therapy Among Patients With Incurable Lung Cancer
154. A phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with non-small cell lung cancer (NSCLC).
155. Gastric Cancer, Version 2.2013
156. Summary of Oral Abstract Session B: Innovating to Improve Care Quality
157. Physiological Imaging-Defined, Response-Driven Subvolumes of a Tumor
158. Palliative Radiation Therapy Practice in Patients With Metastatic Non–Small-Cell Lung Cancer: A Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study
159. Imaging Changes after Stereotactic Radiosurgery of Primary and Secondary Malignant Brain Tumors
160. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma
161. Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 1 of 2 part series)
162. The Optimal Use of Radiotherapy in Small Cell Lung Cancer
163. Small Cell Lung Cancer
164. Imaging in thoracic oncology: case studies from Multidisciplinary Thoracic Tumor Board (part 2 of 2 part series)
165. Variation in the use of intensity-modulated radiation therapy (IMRT) in the state of Michigan: 2005-2010.
166. Combining Physical and Biologic Parameters to Predict Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiation Therapy
167. Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer
168. Changes in Global Function and Regional Ventilation and Perfusion on SPECT During the Course of Radiotherapy in Patients With Non-Small-Cell Lung Cancer
169. Small Cell Lung Cancer
170. Esophageal and Esophagogastric Junction Cancers
171. Modern Approaches to Localized Cancer of the Esophagus
172. The Need for Physician Leadership in Creating a Culture of Safety
173. Features Predicting Sentinel Lymph Node Positivity in Merkel Cell Carcinoma
174. Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET Imaging
175. Improving safety in radiation oncology
176. Development and Validation of a Heart Atlas to Study Cardiac Exposure to Radiation Following Treatment for Breast Cancer
177. In Response to Dr. Wolmark and Colleagues
178. Gastric Cancer
179. Comparative Survival in Patients With Postresection Recurrent Versus Newly Diagnosed Non–Small-Cell Lung Cancer Treated With Radiotherapy
180. Unacceptable Cosmesis in a Protocol Investigating Intensity-Modulated Radiotherapy With Active Breathing Control for Accelerated Partial-Breast Irradiation
181. Accelerated Partial Breast Irradiation: What is Dosimetric Effect of Advanced Technology Approaches?
182. Elevation of Plasma TGF-β1 During Radiation Therapy Predicts Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer: A Combined Analysis From Beijing and Michigan
183. Treatment Recommendations for Locally Advanced, Non-Small-Cell Lung Cancer: The Influence of Physician and Patient Factors
184. Time to Treatment in Patients With Stage III Non–Small Cell Lung Cancer
185. Treatment Summaries in Radiation Oncology and Their Role in Improving Patients' Quality of Care: Past, Present, and Future
186. Designing Targets for Elective Nodal Irradiation in Lung Cancer Radiotherapy: A Planning Study
187. The Effect of Radiation Dose and Chemotherapy on Overall Survival in 237 Patients With Stage III Non–Small-Cell Lung Cancer
188. Using Fluorodeoxyglucose Positron Emission Tomography to Assess Tumor Volume During Radiotherapy for Non–Small-Cell Lung Cancer and Its Potential Impact on Adaptive Dose Escalation and Normal Tissue Sparing
189. Association of 11C-Methionine PET Uptake With Site of Failure After Concurrent Temozolomide and Radiation for Primary Glioblastoma Multiforme
190. Principles and Techniques of Radiation Therapy for Esophageal and Gastroesophageal Junction Cancers
191. Measuring the Quality of Care in Radiation Oncology
192. The predictive role of plasma TGF-β1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer
193. Use of Palliative Radiotherapy Among Patients With Metastatic Non–Small-Cell Lung Cancer
194. PD5-1-5: Radiation-induced elevation in plasma TGF-beta1 during radiation therapy may be predictive of radiation-induced lung toxicity in patients with non-small cell lung cancer: A combined analysis from Beijing and Michigan
195. P3-201: Radiation dose is significantly associated with overall survival in patients with stage III non-small cell lung cancer treated with combined radiation and chemotherapy
196. A Pilot Study of [18F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non–Small-Cell Lung Cancer
197. Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer
198. The Application of Lean Thinking to the Care of Patients With Bone and Brain Metastasis With Radiation Therapy
199. High Radiation Dose May Reduce the Negative Effect of Large Gross Tumor Volume in Patients With Medically Inoperable Early-Stage Non–Small Cell Lung Cancer
200. Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.